X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1378) 1378
humans (1238) 1238
female (917) 917
human-papillomavirus type-16 (635) 635
human papillomavirus (614) 614
cervical cancer (570) 570
type-16 (506) 506
papillomavirus infections (492) 492
cancer (449) 449
oncology (414) 414
adult (384) 384
uterine cervical neoplasms - virology (383) 383
virology (373) 373
papillomavirus infections - virology (363) 363
infection (331) 331
virus-like particles (327) 327
middle aged (326) 326
papillomaviridae - genetics (301) 301
hpv (291) 291
animals (290) 290
immunology (262) 262
cervical-cancer (257) 257
dna (254) 254
vaccines (248) 248
oncogene proteins, viral - genetics (237) 237
health aspects (224) 224
papillomaviridae - immunology (222) 222
papillomavirus infections - prevention & control (220) 220
male (213) 213
aged (212) 212
research (202) 202
women (197) 197
papillomavirus infections - immunology (194) 194
papillomaviruses (193) 193
proteins (190) 190
viruses (189) 189
young-women (184) 184
papillomaviridae - isolation & purification (180) 180
risk factors (180) 180
human papillomavirus 16 - genetics (179) 179
polymerase chain reaction (179) 179
adolescent (174) 174
vaccination (169) 169
uterine cervical neoplasms - prevention & control (168) 168
cervical intraepithelial neoplasia (166) 166
intraepithelial neoplasia (166) 166
papillomavirus infections - complications (166) 166
virus diseases (156) 156
papillomavirus vaccines - immunology (155) 155
particle vaccine (155) 155
infectious diseases (154) 154
analysis (151) 151
oncogene proteins, viral - immunology (148) 148
infections (147) 147
carcinoma, squamous cell - virology (146) 146
risk (145) 145
mice (141) 141
papillomavirus infections - epidemiology (141) 141
dna, viral - analysis (139) 139
prevalence (136) 136
immunization (135) 135
expression (134) 134
medicine, research & experimental (134) 134
squamous-cell carcinoma (130) 130
uterine cervical neoplasms - pathology (128) 128
antibodies (126) 126
human papillomavirus 16 - immunology (126) 126
genetic aspects (123) 123
dna, viral - genetics (121) 121
gene expression (121) 121
microbiology (121) 121
antibodies, viral - blood (120) 120
article (119) 119
biotechnology & applied microbiology (117) 117
vaccine (117) 117
prevention (116) 116
oncogene proteins, viral - metabolism (114) 114
deoxyribonucleic acid--dna (112) 112
biochemistry & molecular biology (109) 109
cervical intraepithelial neoplasia - virology (108) 108
young adult (108) 108
papillomaviridae - classification (107) 107
genomes (106) 106
cervix (105) 105
molecular sequence data (104) 104
papillomavirus infections - pathology (103) 103
uterine cervical neoplasms - immunology (103) 103
tumors (102) 102
randomized controlled-trial (100) 100
research article (99) 99
genotype (98) 98
development and progression (95) 95
papillomavirus vaccines - administration & dosage (94) 94
carcinoma (93) 93
lesions (93) 93
medicine (92) 92
papillomavirus (92) 92
obstetrics & gynecology (91) 91
pathology (89) 89
care and treatment (88) 88
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nucleic Acids Research, ISSN 0305-1048, 12/2013, Volume 41, Issue 22, pp. 10488 - 10508
Journal Article
Plant Biotechnology Journal, ISSN 1467-7644, 06/2008, Volume 6, Issue 5, pp. 427 - 441
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2016, Volume 11, Issue 4, pp. e0152782 - e0152782
Journal Article
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue 28, pp. 4127 - 4134
Highlights ► We investigated the adjuvant activity of CIA06 (CIA05 plus alum) to HPV L1 VLPs. ► The immunogenicity of the CIA06B-adjuvanted vaccine was... 
Allergy and Immunology | Virus-like particle | Human papillomavirus vaccine | CIA06 | Adjuvant system | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN | EFFICACY | TYPE-16 | IMMUNOLOGY | COMBINATION | NEUTRALIZATION ASSAY | COLI DNA FRAGMENTS | PARTICLE VACCINE | MODIFIED LIPOPOLYSACCHARIDES | DOUBLE-BLIND | YOUNG-WOMEN | Oncogene Proteins, Viral - administration & dosage | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Spleen - immunology | Immunoglobulin G - blood | Papillomavirus Vaccines - genetics | Lipopolysaccharides - administration & dosage | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Vaccines, Virosome - immunology | Time Factors | Leukocytes, Mononuclear - immunology | Capsid Proteins - immunology | Female | Oncogene Proteins, Viral - genetics | Adjuvants, Immunologic - isolation & purification | Papillomavirus Vaccines - administration & dosage | Vaccines, Virosome - administration & dosage | Capsid Proteins - administration & dosage | Interferon-gamma - secretion | Injections, Intramuscular | Escherichia coli - chemistry | Vaccines, Virosome - genetics | Animals | B-Lymphocytes - immunology | Immunologic Memory | Papillomavirus Vaccines - immunology | Mice | Mice, Inbred BALB C | Oncogene Proteins, Viral - immunology | Lipopolysaccharides - isolation & purification | Alum Compounds - administration & dosage | Antibodies, Neutralizing - blood | Capsid Proteins - genetics | Human papillomavirus | Vaccines | Cervical cancer | Immune system | Index Medicus
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, pp. e60507 - e60507
Objectives: Naked DNA vaccines can be manufactured simply and are stable at ambient temperature, but require improved delivery technologies to boost... 
ANTIBODIES | SKELETAL-MUSCLE | MULTIDISCIPLINARY SCIENCES | CAPSID PROTEIN EXPRESSION | IN-VIVO | ESCHERICHIA-COLI | TYPE-16 L1 | VIRUS-LIKE PARTICLES | NEUTRALIZATION | HPV | Antibody Specificity | Cell Line | Humans | Vaccination | Vaccines, DNA - immunology | Alphapapillomavirus - classification | Electroporation | Alphapapillomavirus - immunology | Antibodies, Viral - blood | Vaccines, DNA - administration & dosage | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Antibodies, Neutralizing - immunology | Alphapapillomavirus - genetics | Animals | Papillomavirus Infections - prevention & control | Capsid Proteins - immunology | Antibodies, Viral - immunology | Papillomavirus Vaccines - immunology | Mice | Papillomavirus Vaccines - administration & dosage | Antibodies, Neutralizing - blood | Capsid Proteins - genetics | Papillomaviruses | Proteins | Codon | Genes | DNA | Monoclonal antibodies | Genetic engineering | Precipitation (Meteorology) | Temperature requirements | Immunoprecipitation | Spatial discrimination | Viruses | Infections | DNA vaccines | Construction sites | Vaccines | Antibody response | Human papillomavirus | E coli | Ambient temperature | Fusion protein | Deoxyribonucleic acid--DNA | Antigens | Immunization | Immunoglobulins | Risk groups | Vagina | Injection | Gene expression | Virology | Pathology | Immunogenicity | Neutralizing | Cervical cancer | Neutralization | Index Medicus | Deoxyribonucleic acid
Journal Article
Journal of Virological Methods, ISSN 0166-0934, 05/2018, Volume 255, pp. 60 - 65
HPV-16 infection is the most common cause of cervical cancer. As HPV-16 transforms the cell, E6 oncoprotein is over-expressed. Therefore, molecular detection... 
Immunogold-agglutination | HPV-16 | VIROLOGY | HUMAN-PAPILLOMAVIRUS TYPE-16 | INTEGRATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | BIOCHEMICAL RESEARCH METHODS | CERVICAL-CANCER | INFECTION | PREVALENCE | IDENTIFICATION | EXPRESSION | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 10, pp. 1511 - 1522
Abstract HPV 16 L1 capsomeres purified from Escherichia coli represent a promising and potentially cost-effective alternative to the recently licensed... 
Allergy and Immunology | Papillomavirus | Immunization | Capsomeres | Triton X-114 | TLR4 | LPS | MEDICINE, RESEARCH & EXPERIMENTAL | CONTROLLED-TRIAL | NEUTRALIZING ANTIBODIES | HUMAN-PAPILLOMAVIRUS TYPE-16 | ESCHERICHIA-COLI | MAJOR CAPSID PROTEIN | IMMUNOLOGY | CYTOTOXIC T-LYMPHOCYTES | HEAT-SHOCK PROTEINS | VIRUS-LIKE PARTICLES | HEPARAN-SULFATE | MONOCLONAL-ANTIBODIES | Endotoxins - isolation & purification | Papillomavirus Vaccines - genetics | Humans | Drug Contamination - prevention & control | Human papillomavirus 16 - immunology | Recombinant Proteins - isolation & purification | Capsid Proteins - immunology | Papillomavirus Infections - immunology | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Antibodies, Viral - biosynthesis | T-Lymphocytes, Cytotoxic - immunology | Cell Line | Oncogene Proteins, Viral - isolation & purification | Capsid Proteins - isolation & purification | Mice, Inbred C57BL | Uterine Cervical Neoplasms - prevention & control | Escherichia coli - immunology | Papillomavirus Vaccines - isolation & purification | Uterine Cervical Neoplasms - immunology | Recombinant Proteins - genetics | Animals | Endotoxins - immunology | Recombinant Proteins - immunology | Escherichia coli - genetics | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Mice | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Capsid Proteins - genetics | Prevention | Viral antibodies | Oncology, Experimental | Escherichia coli | Water quality | Antibodies | Developing countries | Research | Recombinant proteins | Papillomavirus infections | Cervical cancer | Cancer | Index Medicus
Journal Article